Post by Inpharmus

We are declaring 2026 as Inpharmus’ “Momentum Year.” In this special interview with our CEO, Ismet Ince, we explored how we are advancing across the MERAT region; spanning Türkiye, Saudi Arabia, and Russia with one unified vision, one shared energy, and one strategic mindset. As we transform our regional strength into an integrated powerhouse, we are building an agile, bold, and innovation-driven growth model. As a company focused on rare diseases, our ambition goes beyond expansion. We are committed to redefining patient journeys, addressing unmet medical needs, and creating lasting impact across the region. On our path to achieving a $1 billion valuation, becoming a unicorn, and reaching $500 million in revenue by 2030, our strategy is clear: to push boundaries with a Star & Speed-driven culture, amplify our impact, and help shape the future of healthcare. #inpharmus

Video Content